Peer Review reports
From: Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
| Original Submission | ||
|---|---|---|
| 7 Sep 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 10 Nov 2022 | Reviewed | Reviewer Report |
| 11 Nov 2022 | Reviewed | Reviewer Report - Samah M. Elaidy |
| 18 Dec 2022 | Author responded | Author comments - Honggang Zhou |
| Resubmission - Version 4 | ||
| 18 Dec 2022 | Submitted | Manuscript version 4 |
| 30 Dec 2022 | Author responded | Author comments - Honggang Zhou |
| Resubmission - Version 5 | ||
| 30 Dec 2022 | Submitted | Manuscript version 5 |
| 7 Jan 2023 | Author responded | Author comments - Honggang Zhou |
| Resubmission - Version 6 | ||
| 7 Jan 2023 | Submitted | Manuscript version 6 |
| 18 Jan 2023 | Reviewed | Reviewer Report |
| 22 Jan 2023 | Reviewed | Reviewer Report - Samah M. Elaidy |
| 9 Feb 2023 | Author responded | Author comments - Honggang Zhou |
| Resubmission - Version 7 | ||
| 9 Feb 2023 | Submitted | Manuscript version 7 |
| 15 Feb 2023 | Reviewed | Reviewer Report |
| 8 Mar 2023 | Author responded | Author comments - Honggang Zhou |
| Resubmission - Version 8 | ||
| 8 Mar 2023 | Submitted | Manuscript version 8 |
| Publishing | ||
| 14 Mar 2023 | Editorially accepted | |
| 22 Mar 2023 | Article published | 10.1186/s12890-023-02385-9 |
You can find further information about peer review here.